Stevanato Group S.p.A. $STVN Stock Sold by Cooper Investors PTY Ltd.

by · The Cerbat Gem

Cooper Investors PTY Ltd. trimmed its position in shares of Stevanato Group S.p.A. (NYSE:STVN – Free Report) by 22.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 517,487 shares of the company’s stock after selling 151,007 shares during the quarter. Stevanato Group makes up about 5.8% of Cooper Investors PTY Ltd.’s portfolio, making the stock its 4th biggest holding. Cooper Investors PTY Ltd. owned 0.17% of Stevanato Group worth $10,857,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in STVN. Fifth Third Bancorp boosted its holdings in Stevanato Group by 22.6% during the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock worth $58,000 after buying an additional 773 shares in the last quarter. Integrated Wealth Concepts LLC acquired a new position in shares of Stevanato Group in the second quarter worth about $59,000. Hardy Reed LLC acquired a new position in shares of Stevanato Group in the first quarter worth about $147,000. Diversify Wealth Management LLC boosted its stake in shares of Stevanato Group by 23.9% during the 1st quarter. Diversify Wealth Management LLC now owns 18,353 shares of the company’s stock worth $252,000 after acquiring an additional 3,543 shares in the last quarter. Finally, First Bank & Trust boosted its stake in shares of Stevanato Group by 3.4% during the 2nd quarter. First Bank & Trust now owns 18,417 shares of the company’s stock worth $333,000 after acquiring an additional 603 shares in the last quarter.

Stevanato Group Price Performance

NYSE STVN traded down €0.04 on Tuesday, hitting €19.20. The company had a trading volume of 398,475 shares, compared to its average volume of 501,411. The company has a market capitalization of $5.81 billion, a PE ratio of 34.28, a PEG ratio of 1.59 and a beta of 0.78. The company’s fifty day moving average price is €21.03 and its 200-day moving average price is €18.68. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.61 and a quick ratio of 1.08. Stevanato Group S.p.A. has a 12-month low of €12.89 and a 12-month high of €27.99.

Stevanato Group (NYSE:STVN – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported €0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of €0.15 by (€0.01). Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. The company had revenue of €302.00 million for the quarter. As a group, analysts predict that Stevanato Group S.p.A. will post 0.69 earnings per share for the current year.

Insider Activity at Stevanato Group

In related news, insider Mauro Stocchi sold 13,649 shares of Stevanato Group stock in a transaction dated Monday, September 28th. The stock was sold at an average price of €21.50, for a total value of €293,453.50. Following the sale, the insider directly owned 400,000 shares in the company, valued at approximately €8,600,000. The trade was a 3.30% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Luciano Santel sold 2,023 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of €20.09, for a total value of €40,642.07. Following the sale, the director owned 4,739 shares of the company’s stock, valued at approximately €95,206.51. This trade represents a 29.92% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 21,926 shares of company stock valued at $459,738. 0.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages recently weighed in on STVN. Weiss Ratings upgraded Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 27th. UBS Group began coverage on Stevanato Group in a research report on Wednesday, September 9th. They set a “neutral” rating and a $23.00 price target on the stock. TD Cowen upgraded Stevanato Group to a “strong-buy” rating in a research report on Wednesday, June 17th. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on Stevanato Group in a report on Wednesday, October 7th. They issued a “hold” rating on the stock. Two research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy”.

View Our Latest Report on Stevanato Group

About Stevanato Group

(Free Report)

Stevanato Group S.p.A. is an Italy-based provider of drug-containment, drug-delivery and diagnostic solutions for the pharmaceutical, biotechnology and healthcare industries. The company serves customers across the development, production and administration of injectable medicines, with activities spanning pharmaceutical glass packaging, medical devices and manufacturing technologies.

Its product portfolio includes glass vials, cartridges, syringes and other primary containers, as well as ready-to-use packaging solutions such as EZ-fill.

Featured Stories

Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN – Free Report).